杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/12/18 | 1,921 | 1,925 | 1,902 | 1,915 | -3 | -0.2% | 179,000 |
2020/12/17 | 1,922 | 1,935 | 1,915 | 1,918 | -3 | -0.2% | 120,800 |
2020/12/16 | 1,947 | 1,952 | 1,917 | 1,921 | -11 | -0.6% | 140,400 |
2020/12/15 | 1,951 | 1,976 | 1,929 | 1,932 | -28 | -1.4% | 187,700 |
2020/12/14 | 1,951 | 1,990 | 1,945 | 1,960 | +21 | +1.1% | 224,500 |
2020/12/11 | 1,928 | 1,939 | 1,915 | 1,939 | +12 | +0.6% | 190,500 |
2020/12/10 | 1,897 | 1,932 | 1,895 | 1,927 | +30 | +1.6% | 297,600 |
2020/12/09 | 1,914 | 1,914 | 1,883 | 1,897 | -3 | -0.2% | 266,200 |
2020/12/08 | 1,863 | 1,904 | 1,860 | 1,900 | +27 | +1.4% | 209,300 |
2020/12/07 | 1,893 | 1,897 | 1,870 | 1,873 | -14 | -0.7% | 152,300 |
2020/12/04 | 1,891 | 1,902 | 1,877 | 1,887 | -12 | -0.6% | 139,400 |
2020/12/03 | 1,882 | 1,901 | 1,873 | 1,899 | +24 | +1.3% | 239,000 |
2020/12/02 | 1,891 | 1,892 | 1,870 | 1,875 | -16 | -0.8% | 184,500 |
2020/12/01 | 1,880 | 1,899 | 1,872 | 1,891 | +14 | +0.7% | 169,300 |
2020/11/30 | 1,928 | 1,935 | 1,875 | 1,877 | -22 | -1.2% | 284,000 |
2020/11/27 | 1,877 | 1,903 | 1,875 | 1,899 | +28 | +1.5% | 287,400 |
2020/11/26 | 1,862 | 1,874 | 1,848 | 1,871 | +8 | +0.4% | 143,600 |
2020/11/25 | 1,877 | 1,879 | 1,857 | 1,863 | +7 | +0.4% | 229,200 |
2020/11/24 | 1,885 | 1,886 | 1,856 | 1,856 | -12 | -0.6% | 155,700 |
2020/11/20 | 1,848 | 1,868 | 1,846 | 1,868 | +10 | +0.5% | 110,000 |
2020/11/19 | 1,852 | 1,860 | 1,843 | 1,858 | -6 | -0.3% | 173,700 |
2020/11/18 | 1,861 | 1,867 | 1,852 | 1,864 | -16 | -0.9% | 164,800 |
2020/11/17 | 1,885 | 1,887 | 1,859 | 1,880 | -5 | -0.3% | 182,700 |
2020/11/16 | 1,900 | 1,902 | 1,885 | 1,885 | -11 | -0.6% | 140,900 |
2020/11/13 | 1,910 | 1,912 | 1,889 | 1,896 | -24 | -1.3% | 118,300 |
2020/11/12 | 1,920 | 1,921 | 1,905 | 1,920 | +3 | +0.2% | 123,700 |
2020/11/11 | 1,945 | 1,945 | 1,906 | 1,917 | -5 | -0.3% | 168,200 |
2020/11/10 | 1,950 | 1,950 | 1,903 | 1,922 | -3 | -0.2% | 191,500 |
2020/11/09 | 1,955 | 1,955 | 1,910 | 1,925 | -36 | -1.8% | 224,300 |
2020/11/06 | 1,981 | 1,981 | 1,908 | 1,961 | -24 | -1.2% | 252,400 |
2020/11/05 | 1,960 | 1,987 | 1,951 | 1,985 | +40 | +2.1% | 189,300 |
2020/11/04 | 1,915 | 1,946 | 1,892 | 1,945 | +14 | +0.7% | 178,500 |
2020/11/02 | 1,907 | 1,936 | 1,904 | 1,931 | +42 | +2.2% | 138,800 |
2020/10/30 | 1,899 | 1,900 | 1,880 | 1,889 | -21 | -1.1% | 124,000 |
2020/10/29 | 1,900 | 1,917 | 1,892 | 1,910 | -12 | -0.6% | 93,400 |
2020/10/28 | 1,920 | 1,929 | 1,902 | 1,922 | -9 | -0.5% | 96,000 |
2020/10/27 | 1,928 | 1,934 | 1,911 | 1,931 | -11 | -0.6% | 113,700 |
2020/10/26 | 1,960 | 1,976 | 1,939 | 1,942 | -14 | -0.7% | 95,000 |
2020/10/23 | 1,961 | 1,968 | 1,944 | 1,956 | +2 | +0.1% | 120,700 |
2020/10/22 | 1,968 | 1,968 | 1,945 | 1,954 | -27 | -1.4% | 114,400 |
2020/10/21 | 1,974 | 1,998 | 1,967 | 1,981 | -3 | -0.2% | 133,800 |
2020/10/20 | 2,010 | 2,012 | 1,979 | 1,984 | -30 | -1.5% | 176,900 |
2020/10/19 | 2,019 | 2,034 | 2,012 | 2,014 | -3 | -0.1% | 119,100 |
2020/10/16 | 2,043 | 2,046 | 2,012 | 2,017 | -31 | -1.5% | 108,800 |
2020/10/15 | 2,065 | 2,075 | 2,045 | 2,048 | -17 | -0.8% | 63,400 |
2020/10/14 | 2,100 | 2,107 | 2,061 | 2,065 | -53 | -2.5% | 98,300 |
2020/10/13 | 2,115 | 2,129 | 2,104 | 2,118 | -3 | -0.1% | 76,700 |
2020/10/12 | 2,137 | 2,142 | 2,108 | 2,121 | -11 | -0.5% | 88,400 |
2020/10/09 | 2,138 | 2,138 | 2,109 | 2,132 | -1 | ±0% | 106,400 |
2020/10/08 | 2,170 | 2,170 | 2,132 | 2,133 | -27 | -1.3% | 125,500 |
1051~
1100
件表示中 / 3674件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 136,500円 | +3.2% | +4.5% | 3.81% | 15.68倍 | 0.60倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
持田薬 | 290,300円 | +3.0% | +27.5% | 2.76% | 18.38倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 138,800円 | - | - | 0.00% | - | 64.29倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
栄研化 | 201,200円 | +0.4% | -8.4% | 2.63% | 25.83倍 | 1.46倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ジーエヌアイ | 149,000円 | +21.7% | +999.9% | 0.00% | 6.20倍 | 2.05倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム